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The article by Murali et al. ‘Plant-based formula-
tion in the management of chronic obstructive
pulmonary disease: A randomized double-blind
study’ is interesting.1 Plant-based medicines are
commonly used, especially in India and generally it
is with out any scientific evidence. Ayurvedic
system of medicine which is plant based is claimed
to produce miraculous cures to various diseases for
which allopathic medicine has very little therapeu-
tic response. The authors must be congratulated for
conducting a randomized double-blind placebo
controlled trail to investigate the plant-based
formulation (DCBT1234-Lung KR). However, there
are few drawbacks in the study.
It is well documented that long-term use of such
plant based medicines is associated with heavy
metal poisoning like lead.2,3 The authors have not
mentioned the level of heavy metals in the study
drug. Also, the 6 months duration of the study is too
short for any clinically significant poisoning to
manifest. At least serum levels of various heavy
metals should have been monitored.
The authors have compared the study drug
against oral salbutamol plus theophylline plus
bromhexine. This is an irrational combination which
needs to be discouraged although prevalent in
many parts of India due to its low cost. However,
when conducting a randomized study, it is ideal to
compare the new drug against the existing standard
treatment, which is inhaled bronchodilators. In fact
the GOLD guidelines recommend the use of
bronchodilators via the inhaled route.4
The oral salbutamol especially in combination
with theophyllines has been associated with sig-
nificant cardiovascular toxicity in patients with
COPD.5 Also, addition of oral salbutamol to theo-
phyllines have been found to produce no additional
improvement in lung function in one study.6 The
study would have been better if a simple objectiveee front matter & 2006 Elsevier Ltd. All rights reserve
med.2006.02.028measure of exercise capacity like 6min walk test
was also included in monitoring the response. Also,
authors could have staged the severity of COPD
according to GOLD guideline to analyze whether
the beneficial effect is seen in patients of all
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